Treatment and Opioid Recovery (TOR) Program

Research Focus

The Treatment and Opioid Recovery (TOR) program addresses the opioid overdose crisis in Tribal communities by expanding access to FDA-approved medications for opioid use disorder (MOUD)—such as buprenorphine, methadone, and naltrexone—alongside comprehensive prevention, treatment, and recovery support services. The program recognizes opioid use disorder and co-occurring substance use disorders as interconnected public health challenges requiring integrated clinical and community-based interventions. Beyond opioids, TOR also supports prevention and treatment services for stimulant misuse and use disorders, including cocaine and methamphetamine, reflecting the polysubstance nature of addiction in many Tribal populations. Funded work may span clinical service delivery, implementation science, workforce development, and systems-level approaches to sustain medication-assisted treatment and recovery infrastructure in underserved Tribal settings.

At a Glance

• Who can apply: Tribal organizations, Tribal health systems, and entities serving Tribal communities (specific eligibility criteria not stated)
• Funding & project length: Not stated
• Award / mechanism: Not stated
• Key dates: Not stated
• Best fit for: Public health, addiction medicine, and implementation science researchers focused on Tribal health equity, substance use disorder services, and medication-assisted treatment access